TipRanks
Go Ultimate55% OFF

David Elsley Insider Profile

4 Followers

David Elsley, President & Chief Executive Officer at Cardiol Therapeutics, holds 1.34M shares in Cardiol Therapeutics (Ticker: CRDL). Most recently, David Elsley Bought 100,000 shares of Cardiol Therapeutics on Oct 23, 2025 for an estimated value of $100.00K.

David Elsley's Trading History

CRDL
Cardiol Therapeutics
Oct 23, 2025President & Chief Executive OfficerInformative Buy100.00K$1.49M
CRDL
Insider Shares: 1.34M (153.73%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 23, 2025Informative Buy$100.00K100,000$1.00-4.20%―
Dec 18, 2024Informative BuyC$75.07K40,000C$1.88-24.60%―
Jun 25, 2024Informative BuyC$138.49K50,000C$2.77-31.60%―
Jul 09, 2022Uninformative SellC$0.00600,000C$0.00――
Sep 15, 2021Uninformative SellC$0.00200,000C$0.00――

You May Also Like

David Elsley insider profile FAQ

What is the percentage of profitable transactions made by David Elsley?
The percentage of profitable transactions made by David Elsley is 33%.
What is the average return per transaction made by David Elsley?
The average return per transaction made by David Elsley is -2.10%.
What stocks does David Elsley hold?
David Elsley holds: CRDL stocks.
What was David Elsley’s latest transaction?
David Elsley’s latest transaction was an Informative Buy of $100.00K.
What was David Elsley's most profitable transaction?
David Elsley’s most profitable transaction was an Informative Buy of CRDL stock on June 6, 2020. The return on the trade was 46.80%.
What is David Elsley's role in Cardiol Therapeutics?
David Elsley's role in Cardiol Therapeutics is President & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.